By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Celyad (Formally Known as Cardio3 BioSciences) 

Parc de L’Alliance
9, Boulevard de France
Braine - L’Alleud    1420  Belgium
Phone: 32-2-790-35-30 Fax: 32-2-790-35-35


SEARCH JOBS


Industry
Biotechnology






Company News
Celyad Announces Closing of Its Global Offering 6/24/2015 10:49:06 AM
Celyad Scores $100.1 Million Gross Proceeds With NASDAQ IPO 6/19/2015 7:06:43 AM
Celyad Preps for $99 Million IPO 6/16/2015 7:32:34 AM
Celyad Completes 30-Day Safety Follow-Up Of First Patient In NKG2D Phase I Trial 6/11/2015 7:29:32 AM
Celyad Announces First Quarter 2015 Business Update 5/19/2015 10:50:58 AM
Celyad Says It Might Go Shopping With $115 Million IPO As CAR-T Roars 5/18/2015 1:20:19 PM
Cardio3 Biosciences Announces Results Of Annual Shareholder Assembly 2015 And Confirmation Of Name Change To Celyad 5/5/2015 10:27:15 AM
Cardio3 BioSciences Becomes Celyad 4/15/2015 1:03:38 PM
Cardio3 BioSciences Enrolls First Patient in Phase I Trial For NKG2D CAR T-Cell 4/13/2015 10:48:23 AM
Edison Publishes Research Note On Cardio3 BioSciences, US IPO Intended 4/13/2015 7:04:27 AM
12345678
//-->